Denton B - Search Results

1

¹⁸F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies.

Davenport MS, Montgomery JS, Kunju LP, Siddiqui J, Shankar PR, Rajendiran T, Shao X, Lee E, Denton B, Barnett C, Piert M. Davenport MS, et al. Among authors: denton b. J Nucl Med. 2020 Mar;61(3):337-343. doi: 10.2967/jnumed.119.225789. Epub 2019 Aug 16. J Nucl Med. 2020. PMID: 31420496 Free PMC article. Clinical Trial.

2

Toward better use of bone scans among men with early-stage prostate cancer.

Merdan S, Womble PR, Miller DC, Barnett C, Ye Z, Linsell SM, Montie JE, Denton BT. Merdan S, et al. Urology. 2014 Oct;84(4):793-8. doi: 10.1016/j.urology.2014.06.010. Epub 2014 Aug 2. Urology. 2014. PMID: 25096341 Free PMC article.

3

Clinical predictors and recommendations for staging computed tomography scan among men with prostate cancer.

Risko R, Merdan S, Womble PR, Barnett C, Ye Z, Linsell SM, Montie JE, Miller DC, Denton BT. Risko R, et al. Urology. 2014 Dec;84(6):1329-34. doi: 10.1016/j.urology.2014.07.051. Epub 2014 Oct 5. Urology. 2014. PMID: 25288575 Free PMC article.

4

Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.

Merdan S, Tomlins SA, Barnett CL, Morgan TM, Montie JE, Wei JT, Denton BT. Merdan S, et al. Cancer. 2015 Nov 15;121(22):4071-9. doi: 10.1002/cncr.29611. Epub 2015 Aug 17. Cancer. 2015. PMID: 26280815 Free PMC article.

5

Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan.

Auffenberg GB, Merdan S, Miller DC, Singh K, Stockton BR, Ghani KR, Denton BT. Auffenberg GB, et al. Among authors: denton bt. Urology. 2017 Jun;104:137-142. doi: 10.1016/j.urology.2017.01.039. Epub 2017 Feb 22. Urology. 2017. PMID: 28237530

6

Two-Stage Biomarker Protocols for Improving the Precision of Early Detection of Prostate Cancer.

Barnett CL, Tomlins SA, Underwood DJ, Wei JT, Morgan TM, Montie JE, Denton BT. Barnett CL, et al. Med Decis Making. 2017 Oct;37(7):815-826. doi: 10.1177/0272989X17696996. Epub 2017 Mar 31. Med Decis Making. 2017. PMID: 28363265

7

Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies.

Barnett CL, Auffenberg GB, Cheng Z, Yang F, Wang J, Wei JT, Miller DC, Montie JE, Mamawala M, Denton BT. Barnett CL, et al. Among authors: denton bt. Cancer. 2018 Feb 15;124(4):698-705. doi: 10.1002/cncr.31101. Epub 2017 Nov 13. Cancer. 2018. PMID: 29131319 Free article.

8

Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer.

Barnett CL, Davenport MS, Montgomery JS, Wei JT, Montie JE, Denton BT. Barnett CL, et al. BJU Int. 2018 Jul;122(1):50-58. doi: 10.1111/bju.14151. Epub 2018 Mar 8. BJU Int. 2018. PMID: 29388388 Free article.

9

Temporary Health Impact of Prostate MRI and Transrectal Prostate Biopsy in Active Surveillance Prostate Cancer Patients.

Shankar PR, Maturen KE, George AK, Borza T, Ellimoottil C, Montgomery JS, Wei JT, Denton BT, Davenport MS. Shankar PR, et al. J Am Coll Radiol. 2019 Oct;16(10):1385-1392. doi: 10.1016/j.jacr.2018.11.031. Epub 2019 Feb 4. J Am Coll Radiol. 2019. PMID: 30733160

10

¹⁸F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis.

Barnett CL, Davenport MS, Montgomery JS, Kunju LP, Denton BT, Piert M. Barnett CL, et al. J Nucl Med. 2019 Dec;60(12):1705-1712. doi: 10.2967/jnumed.119.225771. Epub 2019 Jul 26. J Nucl Med. 2019. PMID: 31350321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters